News

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...
The patent comes months after Immunic Therapeutics announced CALLIPER study results, which tested vidofludimus calcium in ...
At the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Stephen ...
Nebraska Medicine has become the first medical center in the world to use allogeneic CAR T-cell therapy to treat multiple sclerosis (MS).
Ocrevus rapidly depletes immune B-cells in people with MS, but ongoing treatment also leads to changes in immune T-cells, a ...
MS advocate and real estate investor Tamiko Ryan talks about the frustrations of getting proper treatments and shares strategies to help you get the support you need to manage MS and thrive. Multiple ...
MILAN -- A path to a cure for multiple sclerosis (MS) may be on the horizon, a top MS researcher suggested. The field faces a great opportunity to advance from suppressing the disease to curing it, ...
Dr. David Gross, an ophthalmologist who practices in Merrillville, took up cycling more more than 20 years ago and has now raised more than $1 million in long-distance rides to find a cure for ...
Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...
Multiple sclerosis (MS) is a chronic, often progressive disease that affects the central nervous system, including the brain, spinal cord, and optic nerves. While the most common symptoms include ...
Over 1,200 cyclists rode in the Bike MS Historic New Bern ride this weekend to fundraise for The National MS Society. As of ...
There's no cure for MS, but one Colorado man living with the disease hopes his perseverance will help raise money for MS research. By day, you'll find John Carrasco running. But at night, you'll find ...